Patent · US Active

Rapidly dispersible dosage form of oxcarbazepine

US9314429B2 · kind B2 · utility

16Cited by
20References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 2015
Grant dateApr 19, 2016
Priority date
Expiry dateAug 27, 2035

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB29K2105/251
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A high dose orodispersible dosage form of oxcarbazepine is provided. Drug-containing particles of oxcarbazepine are included within a porous bound matrix. The dosage form disperses in saliva or water in less than 15 sec and it has sufficient hardness to withstand handling and storage. It can be used to treat diseases or disorders that are therapeutically responsive to oxcarbazepine or a derivative thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.